Organization
Lexeo Therapeutics
4 clinical trials
Clinical trial
A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's AtaxiaStatus: Recruiting, Estimated PCD: 2029-09-01
Clinical trial
A Phase 1/2 Study of the Safety and Efficacy of LX2020 Gene Therapy in Patients With Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic VariantStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Long-Term Follow-Up to Evaluate the Safety of LX1001 in Participants With APOE4 Homozygote Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2028-11-01
Clinical trial
A 52-Week, Multicenter, Phase 1/2 Open-label Study to Evaluate the Safety of LX1001 in Participants With APOE4 Homozygote Alzheimer's DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-11-01